As the coronavirus disease 2019 (COVID-19) pandemic has progressed, the recognition of neurologic sequelae has increased. Herein, we report on a case of COVID-19--associated leukoencephalopathy with microhemorrhage.

A 59-year-old man with known persistent asthma (managed with inhaled steroids and long-acting beta agonists) presented with upper respiratory symptoms (10 days duration) and fever (7 days duration). COVID-19 was confirmed by means of polymerase chain reaction assay. He was intubated on hospital day 6. Severe agitation required high-dose analgesics (including dilaudid, fentanyl, and morphine), and blood pressure required intermittent pressor support (mean, 70--90 mm Hg, without sustained hypertension). Laboratory results included a platelet count of 175 000/μL, an activated partial thromboplastin clotting time of 34.7 seconds, an international normalized ratio of 1.3, a D-dimer level of 11 720 ng/mL, and a fibrinogen level of 693 mg/dL. Lumbar puncture was not performed.

Unenhanced head CT images showed subtle hypoattenuation of the bilateral cerebral hemispheric white matter and corpus callosum ([Fig 1](#fig1){ref-type="fig"}). T2-weighted fluid-attenuated inversion recovery MRI scans of the brain revealed diffuse, confluent posterior predominant white matter hyperintensities, scattered microhemorrhages predominantly in the corpus callosum, and apparent posterior circulation hyperperfusion ([Fig 2](#fig2a){ref-type="fig"}), without diffusion restriction or abnormal enhancement.

![Unenhanced CT image of head demonstrates confluent hypoattenuation in genu (anterior) and splenium (posterior) of corpus callosum (arrows).](radiol.2020201753.fig1){#fig1}

![**(a)** T2-weighted fluid-attenuated inversion recovery MRI scan of brain shows extensive posterior greater than anterior white matter hyperintensity (arrows) without mass effect. **(b)** Susceptibility-weighted image demonstrates a cluster of microhemorrhages in corpus callosum (arrows). **(c)** Arterial-spin-labeling perfusion images are suggestive of posterior circulation hyperperfusion (arrows). CBF = cerebral blood flow.](radiol.2020201753.fig2a){#fig2a}
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These imaging findings are nonspecific and can accompany several well-established leukoencephalopathies. Confluent corpus callosal involvement can occur in acute disseminated encephalomyelitis ([@r1]) or acute hemorrhagic encephalomyelitis ([@r2]). Microbleeds can be seen with these or other vasculitides ([@r3]), as well as with posterior reversible encephalopathy syndrome (note that there was no documented hypertension in this case). Anesthesia-related toxicity is also possible. Although the mechanism of white matter injury and its relationship to COVID-19 is uncertain, possibilities include endotheliitis with thrombotic microangiopathy ([@r4]) as well as COVID-19--associated cytokine release syndrome, which may have implications for treatment ([@r5]).
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